Structure, heterogeneity and developability assessment of therapeutic antibodies

Y Xu, D Wang, B Mason, T Rossomando, N Li, D Liu… - MAbs, 2019 - Taylor & Francis
Increasing attention has been paid to developability assessment with the understanding that
thorough evaluation of monoclonal antibody lead candidates at an early stage can avoid …

Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties

HL Svilenov, P Arosio, T Menzen, P Tessier… - MAbs, 2023 - Taylor & Francis
Antibody drugs should exhibit not only high-binding affinity for their target antigens but also
favorable physicochemical drug-like properties. Such drug-like biophysical properties are …

Carboxyl-functionalized covalent organic framework as a two-dimensional nanofiller for mixed-matrix ultrafiltration membranes

PHH Duong, VA Kuehl, B Mastorovich… - Journal of membrane …, 2019 - Elsevier
A new carboxyl-functionalized covalent organic framework (referred to as COF hereafter,
unless otherwise noted) contains aromatic backbones and carboxyl-functionalized …

A review of tangential flow filtration: process development and applications in the pharmaceutical industry

P Agrawal, K Wilkstein, E Guinn… - … Process Research & …, 2023 - ACS Publications
Tangential flow filtration is an efficient membrane separation technology utilized across a
wide range of industries for separation and purification applications. The requirement of …

Model-based design and process optimization of continuous single pass tangential flow filtration focusing on continuous bioprocessing

MJ Huter, J Strube - Processes, 2019 - mdpi.com
In this study the Single-Pass-Tangential-Flow-Filtration (SPTFF) concept for continuous
ultrafiltration in bioprocessing is investigated. Based on a previously validated physico …

Emerging biomaterials for downstream manufacturing of therapeutic proteins

Y Li, D Stern, LL Lock, J Mills, SH Ou, M Morrow, X Xu… - Acta biomaterialia, 2019 - Elsevier
Downstream processing is considered one of the most challenging phases of industrial
manufacturing of therapeutic proteins, accounting for a large portion of the total production …

Stability of protein pharmaceuticals: Recent advances

MC Manning, RE Holcomb, RW Payne… - Pharmaceutical …, 2024 - Springer
There have been significant advances in the formulation and stabilization of proteins in the
liquid state over the past years since our previous review. Our mechanistic understanding of …

Intensified downstream processing of monoclonal antibodies using membrane technology

S Nadar, G Shooter, B Somasundaram… - Biotechnology …, 2021 - Wiley Online Library
The need to intensify downstream processing of monoclonal antibodies to complement the
advances in upstream productivity has led to increased attention toward implementing …

Deterministic mathematical modeling, sensitivity analysis, and dynamic optimization of cross-flow ultrafiltration systems for concentration of monoclonal antibody …

F Rossi, F da Cunha, E Ximenes, B Bowes, Z Yu… - Computers & Chemical …, 2024 - Elsevier
This manuscript proposes a general new framework for mathematical modeling, extended
sensitivity analysis and dynamic optimization of tangential flow filtration (TFF) systems for …

Strategies for high‐concentration drug substance manufacturing to facilitate subcutaneous administration: A review

M Holstein, J Hung, H Feroz, S Ranjan… - Biotechnology and …, 2020 - Wiley Online Library
To achieve the high protein concentrations required for subcutaneous administration of
biologic therapeutics, numerous manufacturing process challenges are often encountered …